During March, we had the privilege of listening to Jacob Rode, Investor Relations at Novo Nordisk, who gave a digital presentation for our customers. Last year, Novo Nordisk experienced impressive growth, with a 36% increase in sales and a 44% increase in operating profit. This indicates steady growth and strong demand for their products. To meet the continued high demand, the company is expected to almost double its current investments in production in 2024, amounting to DKK 45 billion. During the presentation, they expressed the importance of continuing to build for future growth from an already strong position. It will be exciting to continue to follow the Novo Nordisk success story and how the company’s strategic decisions will affect the company’s development.
